Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for CNV in Angioid Streaks
NCT00599820Phase 3Terminated
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Nov 2005
- Primary completion
- Nov 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in choroidal neovascularization (CNV), sponsored by Asociación para Evitar la Ceguera en México. Started Nov 2005; status: terminated.
02
Drugs
bevacizumab
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT00599820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599820.